These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 27743738)

  • 21. Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group study.
    Tal O; Eitan R; Gemer O; Helpman L; Vaknin Z; Leytes S; Lavie O; Ben-Arie A; Amit A; Namazov A; Ben Shahar I; Atlas I; Bruchim I; Levy T
    Int J Gynecol Cancer; 2021 Nov; 31(11):1437-1442. PubMed ID: 34725243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study.
    Bishop EA; Java JJ; Moore KN; Spirtos NM; Pearl ML; Zivanovic O; Kushner DM; Backes F; Hamilton CA; Geller MA; Hurteau J; Mathews C; Wenham RM; Ramirez PT; Zweizig S; Walker JL
    Am J Obstet Gynecol; 2018 Jan; 218(1):109.e1-109.e11. PubMed ID: 29037481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcomes and relapse patterns of stage IB grade 2 or 3 endometrial cancer treated with adjuvant vaginal brachytherapy.
    Hochreiter A; Kelly JR; Young MR; Litkouhi B; Black JD; Stromberger C; Higgins S; Schwartz PE; Damast S
    Int J Gynecol Cancer; 2020 Jan; 30(1):48-55. PubMed ID: 31722964
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pre-operative wait times in high-grade non-endometrioid endometrial cancer: Do surgical delays impact patient survival?
    Nica A; Sutradhar R; Kupets R; Covens A; Vicus D; Li Q; Ferguson SE; Gien LT
    Gynecol Oncol; 2022 Feb; 164(2):333-340. PubMed ID: 34895897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence.
    Brasky TM; Felix AS; Cohn DE; McMeekin DS; Mutch DG; Creasman WT; Thaker PH; Walker JL; Moore RG; Lele SB; Guntupalli SR; Downs LS; Nagel CI; Boggess JF; Pearl ML; Ioffe OB; Park KJ; Ali S; Brinton LA
    J Natl Cancer Inst; 2017 Mar; 109(3):1-10. PubMed ID: 28376204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of surgical volumes on the survival of endometrial carcinoma.
    Becker JH; Ezendam NP; Boll D; van der Aa M; Pijnenborg JM
    Gynecol Oncol; 2015 Nov; 139(2):306-11. PubMed ID: 26348315
    [No Abstract]   [Full Text] [Related]  

  • 27. Ovarian Carcinoma: A Single-Centre Eight-Year Case-Series Study with Survival Analysis.
    Subtirelu GD; Steriu A; Bratucu E
    Chirurgia (Bucur); 2024 Aug; 119(4):373-384. PubMed ID: 39250607
    [No Abstract]   [Full Text] [Related]  

  • 28. Uterine papillary serous carcinoma pre-operatively diagnosed as endometrioid carcinoma: Is omentectomy necessary?
    Peled Y; Aviram A; Krissi H; Gershoni A; Sabah G; Levavi H; Eitan R
    Aust N Z J Obstet Gynaecol; 2015 Oct; 55(5):498-502. PubMed ID: 26235227
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine serous carcinoma: role of surgery, risk factors and oncologic outcomes. Experience of a tertiary center.
    Ditto A; Leone Roberti Maggiore U; Lopez S; Martinelli F; Bogani G; Lo Vullo S; Brusadelli C; Paolini B; Ducceschi M; Mantiero M; Chiappa V; Signorelli M; Evangelista M; Mariani L; Raspagliesi F
    Eur J Surg Oncol; 2022 Jan; 48(1):268-274. PubMed ID: 34753617
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY).
    Uccella S; Nero C; Vizza E; Vargiu V; Corrado G; Bizzarri N; Ghezzi F; Cosentino F; Turco LC; Fagotti A; Scambia G
    Am J Obstet Gynecol; 2019 Oct; 221(4):324.e1-324.e10. PubMed ID: 31082385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior.
    Bansal N; Herzog TJ; Seshan VE; Schiff PB; Burke WM; Cohen CJ; Wright JD
    Obstet Gynecol; 2008 Jul; 112(1):64-70. PubMed ID: 18591309
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic Oncology Group study ancillary study.
    Garcia-Soto AE; Java JJ; Nieves Neira W; Pearson JM; Cohn DE; Lele SB; Tewari KS; Walker JL; Alvarez Secord A; Armstrong DK; Copeland LJ
    Gynecol Oncol; 2016 Dec; 143(3):484-489. PubMed ID: 27726923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Invasive Epithelial Ovarian Cancer Survival by Histotype and Disease Stage.
    Peres LC; Cushing-Haugen KL; Köbel M; Harris HR; Berchuck A; Rossing MA; Schildkraut JM; Doherty JA
    J Natl Cancer Inst; 2019 Jan; 111(1):60-68. PubMed ID: 29718305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optimal cytoreductive surgery in patients with advanced uterine carcinosarcoma: A multi-institutional retrospective study from the Japanese gynecologic oncology group.
    Harano K; Hirakawa A; Yunokawa M; Nakamura T; Satoh T; Nishikawa T; Aoki D; Ito K; Ito K; Nakanishi T; Susumu N; Takehara K; Watanabe Y; Watari H; Saito T
    Gynecol Oncol; 2016 Jun; 141(3):447-453. PubMed ID: 27072806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathologic and Treatment Outcomes Among a Geriatric Population of Endometrial Cancer Patients: An NRG Oncology/Gynecologic Oncology Group Ancillary Data Analysis of LAP2.
    Bishop EA; Java JJ; Moore KN; Walker JL
    Int J Gynecol Cancer; 2017 May; 27(4):730-737. PubMed ID: 28399028
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer.
    Soliman PT; Westin SN; Dioun S; Sun CC; Euscher E; Munsell MF; Fleming ND; Levenback C; Frumovitz M; Ramirez PT; Lu KH
    Gynecol Oncol; 2017 Aug; 146(2):234-239. PubMed ID: 28528918
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of outcomes in early stage uterine carcinosarcoma and uterine serous carcinoma.
    Desai NB; Kollmeier MA; Makker V; Levine DA; Abu-Rustum NR; Alektiar KM
    Gynecol Oncol; 2014 Oct; 135(1):49-53. PubMed ID: 25084509
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic Oncology Group study.
    Rose PG; Java JJ; Morgan MA; Alvarez-Secord A; Kesterson JP; Stehman FB; Warshal DP; Creasman WT; Hanjani P; Morris RT; Copeland LJ
    Gynecol Oncol; 2016 Dec; 143(3):511-515. PubMed ID: 27692669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
    Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
    Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.